Status:
UNKNOWN
Genetics and Psychopathology in the 22q11 Deletion Syndrome
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Netherlands Brain Foundation
Children's Hospital of Philadelphia
Conditions:
Chromosome 22q11.2 Deletion Syndrome
Eligibility:
All Genders
8-20 years
Brief Summary
The purposes of this study are to: 1. study the nature and longitudinal course of psychiatric symptoms in children with the 22q11.2 deletion syndrome and 2. identify genes that contribute to the occu...
Detailed Description
The study of genes that are implicated in various mental diseases is increasingly relevant. The association between a gene and a disease can provide valuable information on how the neurobiology of the...
Eligibility Criteria
Inclusion
- 22q11.2 deletion confirmed with fluorescence in-situ hybridization (FISH)
Exclusion
- None
Key Trial Info
Start Date :
October 1 2002
Trial Type :
OBSERVATIONAL
End Date :
October 1 2012
Estimated Enrollment :
175 Patients enrolled
Trial Details
Trial ID
NCT00161109
Start Date
October 1 2002
End Date
October 1 2012
Last Update
October 13 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Philadelphia, Dpt of Genetics and Dpt of Child and Adolescent Psychiatry
Philadelphia, Pennsylvania, United States, 19104
2
UMC Utrecht, Dpt of Child and Adolescent Psychiatry
Utrecht, Netherlands, 3508 GA